The purpose of the study is to determine the safety and efficacy of TRC150094 in male
patients with cardiometabolic risk. Cardiometabolic risk which is the overall risk of
cardiovascular disease (CVD) and diabetes resulting from the presence of hypertension, HDL
cholesterol, insulin resistance, dysglycemia and visceral obesity.